RVMD
Revolution Medicines Inc
NASDAQ: RVMD · HEALTHCARE · BIOTECHNOLOGY
$140.55
-2.96% today
Updated 2026-04-29
Market cap
$29.88B
P/E ratio
—
P/S ratio
9,035.10x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$34 – $156
Volume
3.1M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D7.3
Quality
B+3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
3.3
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$174.30
+24.01%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
4 Strong Buy17 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 3.27 — safe zone
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-276.16M
- Revenue declining -95.20% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $35.38M | $11.58M | $0.00 | $0.00 | $742000.00 | $0.1B |
| Net income | $-248.71M | $-436.37M | $-600.09M | $-1.13B | $-364.89M | — |
| EPS | — | — | — | — | $-5.95 | $-7.47 |
| Free cash flow | $-235.22M | $-358.30M | $-567.74M | $-913.73M | $-276.16M | — |
| Profit margin | -702.95% | -3,768.28% | — | — | — | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-15 | GOLDSMITH, MARK A | Sale | 96,756 | — |
| 2026-04-15 | GOLDSMITH, MARK A | Sale | 23,244 | — |
| 2026-04-15 | GOLDSMITH, MARK A | Sale | 120,000 | $150.09 |
Peer comparison
Smart narrative
Revolution Medicines Inc trades at $140.55. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 3.27, it sits in the safe zone. TTM revenue stands at $742000.00.
Frequently asked questions
What is Revolution Medicines Inc's stock price?
Revolution Medicines Inc (RVMD) trades at $140.55.
Is Revolution Medicines Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Revolution Medicines Inc (RVMD)?
The analyst target price is $174.30, representing +24.0% upside from the current price of $140.55.
What is the future stock price of RVMD by 2030?
Our research-backed model estimates Revolution Medicines Inc could reach $152.58 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Revolution Medicines Inc's revenue?
TTM revenue is $742000.00.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
3.27 — safe zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio9,035.10x
ROE-58.10%
Beta1.01
50D MA$109.98
200D MA$75.30
Shares out0.21B
Float0.18B
Short ratio—
Avg volume3.1M
Performance
1 week+3.88%
1 month+42.49%
3 months+44.97%
YTD+76.46%
1 year—
3 years—
5 years—